fbpx

Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder

CDKL5 deficiency disorder (CDD) is associated with refractory infantile onset epilepsy, global developmental delay, and variable features that include sleep, behavioral disturbances, and movement disorders. Current treatment is primarily symptom-based and informed by experience in caring for this population.

The post Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder appeared first on Society of Cannabis Clinicians.

Leave a Reply

%d bloggers like this: